Premium
Anti‐angiogenesis drugs in lung cancer
Author(s) -
LEE Siow Ming,
BAAS Paul,
WAKELEE Heather
Publication year - 2010
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2010.01715.x
Subject(s) - medicine , lung cancer , angiogenesis , intensive care medicine , cancer , lung , oncology , cancer research
In the last years much attention has been given to the implementation of the so‐called targeted drugs. One of the targets of tumours is the vasculature and this has led to the development of anti‐angiogenic drugs. In lung cancer the use of these drugs has resulted in both positive and negative studies. In this paper the pros and cons are presented. We hope that this information will help the physician in making a proper treatment choice.